ALTHOUGH the recovery theme has been the focus of investors in the weeks closing out 2020 and entering 2021, analysts caution that it is not a broad-based nor clear-cut theme because there are still many uncertainties ahead, even though vaccines for Covid-19 are now available.
Be selective and study the stocks, as not all in the recommended sectors will deliver, cautions Areca Capital CEO Danny Wong, following a 34-point slump in the KLCI in the new year on the back of profit-taking focused on glove makers and banking counters before losses were slightly pared and the benchmark closed at the 1,602 level.
“This first week of the year has been a guide for us. Those who want to participate in the market can tell that 1H2021 should be better than last year on account of positive vaccine news, better business sentiment and the notion that most businesses will see recovery in earnings over the next two quarters,” Wong tells The Edge, noting that longer-term investments with a two- to